Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy.
Piccart MJ, Floquet A, Scarfone G, Willemse PH, Emerich J, Vergote I, Giurgea L, Coens C, Awada A, Vermorken JB. Piccart MJ, et al. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:196-203. doi: 10.1111/j.1525-1438.2003.13360.x. Int J Gynecol Cancer. 2003. PMID: 14656280 Clinical Trial.
Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex.
Dodion PF, de Valeriola D, Crespeigne N, Kantrowitz JD, Piccart M, Wery F, Kerger J, Egorin MJ, Forrest A, Bachur NR, et al. Dodion PF, et al. Among authors: piccart m. Ann Oncol. 1991 Sep;2(8):589-96. doi: 10.1093/oxfordjournals.annonc.a058026. Ann Oncol. 1991. PMID: 1793726 Free article. Clinical Trial.
Intraperitoneal chemotherapy with cisplatin and melphalan.
Piccart MJ, Abrams J, Dodion PF, Crespeigne N, Sculier JP, Pector JC, Finet C, Nouwijnck C, Bondue H, Atassi G, et al. Piccart MJ, et al. J Natl Cancer Inst. 1988 Sep 21;80(14):1118-24. doi: 10.1093/jnci/80.14.1118. J Natl Cancer Inst. 1988. PMID: 3411624
An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapy-naive patients with locally advanced or metastatic breast cancer.
Piccart MJ, Bruning P, Wildiers J, Awada A, Schornagel JH, Thomas J, Tomiak E, Bartholomeus S, Witteveen PO, Paridaens R. Piccart MJ, et al. Ann Oncol. 1995 Sep;6(7):673-7. doi: 10.1093/oxfordjournals.annonc.a059283. Ann Oncol. 1995. PMID: 8664188 Free article. Clinical Trial.
598 results